Two-dimensional liquid chromatography (2D-LC) improves chromatographic performance, with LCxLC providing extensive ...

Megan Funk can relate to anxiety that EMS providers might have regarding patient medication dosages, so she provides numerous tips and tricks to help ease that anxiety. One of the most important parts ...

Introduction Stroke is the second leading cause of death and disability creating a huge economic burden annually. Robot-assisted training (RT) is a promising therapy in stroke rehabilitation, but for ...

Controlling the state of a cell in a desired direction is one of the central challenges in life sciences, including drug ...

Controlling the state of a cell in a desired direction is one of the central challenges in life sciences, including drug development, cancer treatment, and regenerative medicine.

Understanding the interaction between immune cells and cancer cells has important implications for cancer immunotherapies, ...

WATERTOWN, Mass. - C4 Therapeutics, Inc. (NASDAQ:CCCC), a clinical-stage biopharmaceutical company with a market capitalization of $225 million, reported Saturday that its investigational oral drug ...

Iberdomide combined with Darzalex and dexamethasone significantly improved MRD negativity rates in relapsed or refractory multiple myeloma patients. The EXCALIBER-RRMM trial continues to evaluate ...

Figure 6. Senescent heterogeneity model based on DNA content. Compared to G1-arrested cells, G2-arrested senescent cells express higher levels of senescence-associated markers, secrete more IL-6, and ...

IB SA Answer Key 2025 PDF released on mha.gov.in candidates can login with registration ID and password to check correct answers and marked responses IB SA Answer Key 2025 PDF now available candidates ...

Investing.com -- Scholar Rock (NASDAQ:SRRK) stock fell 14% Tuesday after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s spinal muscular atrophy ...

Investing.com - Pharmaceutical industry group PhRMA has made the first move ahead of President Trump’s September 29 drug pricing deadline, according to Bernstein analyst Courtney Breen. Leading ...